Pharma

Hvivo raises full year sales and earnings guidance after ‘excellent’ start to 2023

The Dublin-headquartered pharmaceutical services company said it expects to generate full year sales of £55m and earnings margins of 19 per cent

Cathal Friel, the founder of Hvivo